Deirdre Gillespie - Net Worth and Insider Trading

Deirdre Gillespie Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Deirdre Gillespie owns 2 companies in total, including Seelos Therapeutics Inc (SEEL) , and La Jolla Pharmaceutical Co (LJPC) .

Click here to see the complete history of Deirdre Gillespie’s form 4 insider trades.

Insider Ownership Summary of Deirdre Gillespie

Ticker	Comapny	Transaction Date	Type of Owner
SEEL	Seelos Therapeutics Inc	2014-01-02	director
LJPC	La Jolla Pharmaceutical Co	2006-03-15	director & CEO

Deirdre Gillespie Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Deirdre Gillespie Ownership Network

Ownership Network List of Deirdre Gillespie

No Data

Ownership Network Relation of Deirdre Gillespie

Deirdre Gillespie Owned Company Details

What does Seelos Therapeutics Inc do?

Who are the key executives at Seelos Therapeutics Inc?

Deirdre Gillespie is the director of Seelos Therapeutics Inc. Other key executives at Seelos Therapeutics Inc include director & See Remarks Raj Mehra , Chief Financial Officer Michael Joseph Golembiewski , and director & CEO & Secretary Richard W Pascoe .

Seelos Therapeutics Inc (SEEL) Insider Trades Summary

Over the past 18 months, Deirdre Gillespie made no insider transaction in Seelos Therapeutics Inc (SEEL). Other recent insider transactions involving Seelos Therapeutics Inc (SEEL) include a net purchase of 83,000 shares made by Michael Joseph Golembiewski , and a net purchase of 75,757 shares made by Raj Mehra .

In summary, during the past 3 months, insiders sold 0 shares of Seelos Therapeutics Inc (SEEL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Seelos Therapeutics Inc (SEEL) were sold and 1,240 shares were bought by its insiders, resulting in a net purchase of 1,240 shares.

Seelos Therapeutics Inc (SEEL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Seelos Therapeutics Inc Insider Transactions

No Available Data

Deirdre Gillespie Mailing Address

Above is the net worth, insider trading, and ownership report for Deirdre Gillespie. You might contact Deirdre Gillespie via mailing address: 416 Marlborough Street, Apt. 707, Boston Ma 02115.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.